Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2009;40:1578-1584
Published online before print March 12, 2009, doi: 10.1161/STROKEAHA.108.540492
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
40/5/1578    most recent
STROKEAHA.108.540492v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chuang, S.-Y.
Right arrow Articles by Pan, W.-H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chuang, S.-Y.
Right arrow Articles by Pan, W.-H.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*Stroke
Related Collections
Right arrow Cerebrovascular disease/stroke
Right arrow Risk Factors
Right arrow Fibrinogen/fibrin

(Stroke. 2009;40:1578.)
© 2009 American Heart Association, Inc.


Original Contributions

Fibrinogen Independently Predicts the Development of Ischemic Stroke in a Taiwanese Population

CVDFACTS Study

Shao-Yuan Chuang, PhD; Chyi-Huey Bai, PhD; Wei-Hung Chen, MD; Li-Ming Lien, MD Wen-Harn Pan, PhD

From the Institute of Biomedical Sciences (S.-Y.C., W.-H.P.), Academia Sinica, Taipei, Taiwan; Department of Neurology (W.-H.C., L.-M.L.), Central Laboratory (C.-H.B.), Shin Kong WHS Memorial Hospital, Taipei, Taiwan; and the School of Public Health (C.-H.B.), Taipei Medical University, Taipei, Taiwan.

Correspondence to Wen-Harn Pan, PhD, R141, Institute of Biomedical Sciences, Academica Sinica, Taipei 11529, Taiwán. E-mail pan{at}ibms.sinica.edu.tw

Background and Purpose— Of few prospective studies that have focused on the relationship between fibrinogen and ischemic stroke (IS) in Asian populations, the findings were inconsistent with those conducted in Western countries. Therefore, we aimed to investigate the temporal relationship between fibrinogen levels (plus several related parameters) and IS in a community-based study in Taiwan.

Methods— Baseline data from 3281 adults (≥20 years of age) in the Cardiovascular Diseases Risk Factor Two-Township Study were linked to incidental IS status derived from insurance claims and death certificate records. Hazard ratios and 95% CIs of clotting factors (fibrinogen, factor VII, factor VIII, and antithrombin-III) for IS events were estimated using Cox proportional hazard models.

Results— With 10.4 years (average) follow-up, 128 persons developed IS (3.75 per 1000 person-years). As expected, elevated blood pressure and diabetes were independent predictors of IS events. A dose-response relationship was found in univariate analysis between IS risk and tertiles of fibrinogen (hazard ratio, 3.73; 2.19 to 1.00), factor VII (hazard ratio, 1.86; 1.35 to 1.00), and factor VIII (2.97; 1.70 to 1.00), respectively, but not for antithrombin-III. After adjusting for confounding and known risk factors, fibrinogen independently predicted IS events. A 72% increase (hazard ratio, 1.72; 1.02 to 2.90) in IS risk was observed for individuals with fibrinogen ≥8.79 µmol/L compared with those <7.03 µmol/L.

Conclusions— In addition to hypertension and diabetes, fibrinogen independently predicted future IS risk. We suggest that fibrinogen may be considered in the risk assessment model for IS in the Taiwanese population.


Key Words: fibrinogen • ischemic stroke • prospective study • risk equation • Taiwanese